Gene · 1643
Papers2,095
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,095
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arsenite Impairs BRCA1-Dependent DNA Double-Strand Break Repair, a Mechanism Potentially Contributing to Genomic Instability. | Int J Mol Sci | 2023 | 37762697 | PubTator, text mining | PubMed |
| Whole-Genome Resequencing Reveals Selection Signal Related to Sheep Wool Fineness. | Animals (Basel) | 2023 | 37760343 | PubTator, text mining | PubMed |
| Mapping the recognition pathway of cyclobutane pyrimidine dimer in DNA by Rad4/XPC. | Nucleic Acids Res | 2023 | 37757853 | PubTator, text mining | PubMed |
| Pulse-SILAC and Interactomics Reveal Distinct DDB1-CUL4-Associated Factors, Cellular Functions, and Protein Substrates. | Mol Cell Proteomics | 2023 | 37689310 | PubTator, text mining | PubMed |
| DDB2 and MDM2 genes are promising markers for radiation diagnosis and estimation of radiation dose independent of trauma and burns. | Funct Integr Genomics | 2023 | 37688632 | PubTator, text mining | PubMed |
| CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. | Exp Hematol Oncol | 2023 | 37679762 | PubTator, text mining | PubMed |
| Prognostic value of GLCE and infiltrating immune cells in Ewing sarcoma. | Heliyon | 2023 | 37662777 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Acne Vulgaris. | Int J Gen Med | 2023 | 37662507 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity. | Int J Oncol | 2023 | 37654197 | PubTator, text mining | PubMed |
| Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements. | Nucleic Acids Res | 2023 | 37650627 | PubTator, text mining | PubMed |
| Hypoxia-driven ncRNAs in breast cancer. | Front Oncol | 2023 | 37583933 | PubTator, text mining | PubMed |
| Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report. | BMC Med Genomics | 2023 | 37573316 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs. | Int J Mol Sci | 2023 | 37569792 | PubTator, text mining | PubMed |
| Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level. | Cancers (Basel) | 2023 | 37568720 | PubTator, text mining | PubMed |
| Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate. | Int J Radiat Biol | 2023 | 37549410 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of DNA damage repair in germ cell development. | Front Endocrinol (Lausanne) | 2023 | 37529603 | PubTator, text mining | PubMed |
| A half century of exploring DNA excision repair in chromatin. | J Biol Chem | 2023 | 37527775 | PubTator, text mining | PubMed |
| The Over-Irradiation Metabolite Derivative, 24-Hydroxylumister-ol3, Reduces UV-Induced Damage in Skin. | Metabolites | 2023 | 37512482 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1643/papers?page=7